Exascale Labs Holdings Inc. Class A Common Stock (NASDAQ:XLAB) — Stock Price

$0.97 USD
▼ -4.52% today

Exascale Labs Holdings Inc. Class A Common Stock (NASDAQ:XLAB) is currently trading at $0.97 USD, down 4.52% today. Over the past 52 weeks, shares have ranged between $0.97 and $3.81. This page tracks Exascale Labs Holdings Inc. Class A Common Stock's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Exascale Labs Holdings Inc. Class A Comm operating cash flow efficiency.

Exascale Labs Holdings Inc. Class A Common Stock (XLAB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Exascale Labs Holdings Inc. Class A Common Stock's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Exascale Labs Holdings Inc. Class A Common Stock Income Statement — Revenue, Profit & Earnings by Year

Exascale Labs Holdings Inc. Class A Common Stock's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024
Total Revenue $7.02 Million $1.32 Million
Cost of Revenue $5.91 Million $1.26 Million
Gross Profit $1.11 Million $55.57K
Research & Development $2.80 Million $1.37 Million
SG&A $1.35 Million $535.96K
Total Operating Expenses $10.06 Million $3.16 Million
Operating Income $-3.04 Million $-1.85 Million
EBITDA $-3.04 Million $-1.84 Million
EBIT $-3.04 Million $-1.85 Million
Interest Expense — —
Income Before Tax $-7.66 Million $-4.96 Million
Income Tax Expense — —
Net Income $-7.66 Million $-4.96 Million

Exascale Labs Holdings Inc. Class A Common Stock Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Exascale Labs Holdings Inc. Class A Common Stock's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024
Total Assets $7.32 Million $4.39 Million
Total Current Assets $7.30 Million $4.37 Million
Cash & Equivalents — —
Short-term Investments — —
Net Receivables $152.54K $123.33K
Inventory — —
Property, Plant & Equipment — —
Goodwill — —
Total Liabilities $20.32 Million $9.88 Million
Total Current Liabilities $20.32 Million $9.88 Million
Long-term Debt — —
Net Debt — —
Total Stockholder Equity $-13.00 Million $-5.49 Million
Retained Earnings $-13.22 Million $-5.56 Million

Exascale Labs Holdings Inc. Class A Common Stock Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Exascale Labs Holdings Inc. Class A Common Stock generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024
Operating Cash Flow $-1.01 Million $-560.91K
Capital Expenditures $2.14K $27.81K
Free Cash Flow $-1.01 Million $-588.72K
Investing Cash Flow — —
Financing Cash Flow $4.28 Million $1.28 Million
Dividends Paid — —
Stock-Based Compensation $153.27K $21.10K
Depreciation $6.23K $4.11K
Change in Cash $3.26 Million $696.28K

Exascale Labs Holdings Inc. Class A Common Stock Earnings History — EPS Actual vs. Analyst Estimates

Track Exascale Labs Holdings Inc. Class A Common Stock's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jun 30, 2026 0.05 — —
Mar 31, 2026 0.05 — —
Dec 31, 2025 0.06 — —
Sep 30, 2025 0.05 — —